AKT1 and breast carcinoma: PD suppresses the lung metastasis of breast cancer by downregulating PD-L1 expression and enhances the anticancer effects of sorafenib in AKT-positive and PTEN-negative prostate cancer cells through the ubiquitination of p-Akt 119, 120.